Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $149.4500 (-0.74%) ($148.1900 - $150.7500) on Mon. Mar. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.02% (three month average) | RSI | 68 | Latest Price | $149.4500(-0.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(43%) SPLV(34%) XLP(31%) DIA(30%) VYM(30%) | Factors Impacting ABBV price | ABBV will decline at least -0.51% in a week (0% probabilities). VIXM(-19%) UUP(-12%) TBT(-3%) EDOC(-2%) VXX(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.51% (StdDev 1.02%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
5 Day Moving Average | $149.54(-0.06%) | 10 Day Moving Average | $148.35(0.74%) | 20 Day Moving Average | $146.12(2.28%) | To recent high | -0.7% | To recent low | 23% | Market Cap | $263.672b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |